Back to Results
First PageMeta Content
Diabetes mellitus / SLC5A2 / Anti-diabetic medication / Diabetes / Health / Medicine


April 1, 2013 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation U.S. FDA Approves Canagliflozin (TA[removed]for the Treatment of Adult Patients with Type 2 Diabetes
Add to Reading List

Document Date: 2013-04-01 21:51:25

Open Document

File Size: 19,62 KB

Share Result on Facebook

City

Osaka / /

Company

PRESS RELEASE Mitsubishi Tanabe Pharma Corporation / Mitsubishi Tanabe Pharma Corporation / Tanabe Seiyaku Ltd. / Janssen Pharmaceuticals Inc. / /

Continent

South America / Asia / Africa / North America / Europe / /

Country

Australia / Japan / United States / New Zealand / /

Event

FDA Phase / /

IndustryTerm

manufacturing / /

MedicalCondition

diabetes mellitus / disease / diabetes / /

Organization

FDA / Ministry of Health / /

/

Product

United States / /

Region

Middle East / /

SocialTag